Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]
Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]
Argobio Studio has announced the successful seed financing of Enodia [...]
Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]
Ona Therapeutics has appointed Antoine Yver as chair of its [...]
From synthetic biology to patient access, AI-powered formulation to sustainable [...]
InflaRx has reported its Q2 2025 results and provided updates [...]
Sofinnova Partners has announced a new collaboration with NVIDIA to [...]
New approach targets Elk1 to restore neuroplasticity without sedation or [...]